As of 9:30 AM on the 4th, Shinpung Pharmaceutical is trading at 150,000 KRW, down 4.15% from the previous day. This represents a 108.91% increase compared to August 12. Shinpung Pharmaceutical is known as a pharmaceutical company focused on the sales of specialized therapeutic drugs.

Over the past five days, individual investors have net sold 1,640,066 shares, while foreigners and institutions have net bought 1,758,663 shares and net sold 116,101 shares, respectively.


On September 1, Shinpung Pharmaceutical became a market topic with the news "US NIH COVID-19 'Pyramax' large-scale Phase 2 clinical trial in South Africa..."



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing